These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 29288451)

  • 21. Diversity of phage infection types and associated terminology: the problem with 'Lytic or lysogenic'.
    Hobbs Z; Abedon ST
    FEMS Microbiol Lett; 2016 Apr; 363(7):. PubMed ID: 26925588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacteria-phage interactions in natural environments.
    Díaz-Muñoz SL; Koskella B
    Adv Appl Microbiol; 2014; 89():135-83. PubMed ID: 25131402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promises and Pitfalls of In Vivo Evolution to Improve Phage Therapy.
    Bull JJ; Levin BR; Molineux IJ
    Viruses; 2019 Nov; 11(12):. PubMed ID: 31766537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Further Considerations on How to Improve Phage Therapy Experimentation, Practice, and Reporting: Pharmacodynamics Perspectives.
    Abedon ST
    Phage (New Rochelle); 2022 Jun; 3(2):98-111. PubMed ID: 36148139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of phages, bacteria, and the human immune system: Evolutionary changes in phage therapy.
    Jariah ROA; Hakim MS
    Rev Med Virol; 2019 Sep; 29(5):e2055. PubMed ID: 31145517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacteriophage Clinical Use as Antibacterial "Drugs": Utility and Precedent.
    Abedon ST
    Microbiol Spectr; 2017 Aug; 5(4):. PubMed ID: 28840811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biocontrol of phytobacteria with bacteriophage cocktails.
    Kering KK; Kibii BJ; Wei H
    Pest Manag Sci; 2019 Jul; 75(7):1775-1781. PubMed ID: 30624034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacteriophages and its applications: an overview.
    Sharma S; Chatterjee S; Datta S; Prasad R; Dubey D; Prasad RK; Vairale MG
    Folia Microbiol (Praha); 2017 Jan; 62(1):17-55. PubMed ID: 27718043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacteriophage-host arm race: an update on the mechanism of phage resistance in bacteria and revenge of the phage with the perspective for phage therapy.
    Azam AH; Tanji Y
    Appl Microbiol Biotechnol; 2019 Mar; 103(5):2121-2131. PubMed ID: 30680434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacteriophage secondary infection.
    Abedon ST
    Virol Sin; 2015 Feb; 30(1):3-10. PubMed ID: 25595214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phage therapy efficacy: a review of the last 10 years of preclinical studies.
    Melo LDR; Oliveira H; Pires DP; Dabrowska K; Azeredo J
    Crit Rev Microbiol; 2020 Feb; 46(1):78-99. PubMed ID: 32091280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A minireview on the in vitro and in vivo experiments with anti-Escherichia coli O157:H7 phages as potential biocontrol and phage therapy agents.
    Sabouri S; Sepehrizadeh Z; Amirpour-Rostami S; Skurnik M
    Int J Food Microbiol; 2017 Feb; 243():52-57. PubMed ID: 27978506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delivering phage therapy per os: benefits and barriers.
    Zelasko S; Gorski A; Dabrowska K
    Expert Rev Anti Infect Ther; 2017 Feb; 15(2):167-179. PubMed ID: 27885865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolutionary Rationale for Phages as Complements of Antibiotics.
    Torres-Barceló C; Hochberg ME
    Trends Microbiol; 2016 Apr; 24(4):249-256. PubMed ID: 26786863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Control of Multidrug-Resistant Gene Flow in the Environment Through Bacteriophage Intervention.
    Parmar KM; Hathi ZJ; Dafale NA
    Appl Biochem Biotechnol; 2017 Mar; 181(3):1007-1029. PubMed ID: 27723009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phage Therapy: A New Horizon in the Antibacterial Treatment of Oral Pathogens.
    Shlezinger M; Khalifa L; Houri-Haddad Y; Coppenhagen-Glazer S; Resch G; Que YA; Beyth S; Dorfman E; Hazan R; Beyth N
    Curr Top Med Chem; 2017; 17(10):1199-1211. PubMed ID: 27770768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phage Therapy Approaches to Reducing Pathogen Persistence and Transmission in Animal Production Environments: Opportunities and Challenges.
    Colavecchio A; Goodridge LD
    Microbiol Spectr; 2017 Jun; 5(3):. PubMed ID: 28664828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bacteriophages in the battle against multidrug resistant bacteria].
    van der Meer JWM; Vandenbroucke-Grauls CMJE
    Ned Tijdschr Geneeskd; 2018; 162():D2433. PubMed ID: 29600928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization and in vitro evaluation of new bacteriophages for the biocontrol of Escherichia coli.
    Pereira C; Moreirinha C; Lewicka M; Almeida P; Clemente C; Romalde JL; Nunes ML; Almeida A
    Virus Res; 2017 Jan; 227():171-182. PubMed ID: 27756632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings.
    Niu YD; Hyun JE; Nguyen N
    J Vis Exp; 2021 Aug; (174):. PubMed ID: 34487111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.